Risk of adverse events among older adults following co-prescription of clarithromycin and statins not metabolized by cytochrome P450 3A4

BACKGROUND: The cytochrome P450 3A4 (CYP3A4) inhibitor clarithromycin may also inhibit liver-specific organic anion–transporting polypeptides (OATP1B1 and OATP1B3). We studied whether concurrent use of clarithromycin and a statin not metabolized by CYP3A4 was associated with an increased frequency o...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:CMAJ
Main Authors: Li, Daniel Q., Kim, Richard, McArthur, Eric, Fleet, Jamie L., Bailey, David G., Juurlink, David, Shariff, Salimah Z., Gomes, Tara, Mamdani, Muhammad, Gandhi, Sonja, Dixon, Stephanie, Garg, Amit X.
פורמט: Artigo
שפה:Inglês
יצא לאור: 8872147 Canada Inc. 2015
נושאים:
Research
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC4330139/
https://ncbi.nlm.nih.gov/pubmed/25534598
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1503/cmaj.140950
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים